Sage Journals: Discover world-class research

Abstract

Get full access to this article

View all access options for this article.

References

Singh

Loke

Furberg

. Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis. JAMA 2007;298:1189–95.

Nissen

Wolski

. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 2007; DOI: 10.1056/NEJ-Moa072761.

Lincoff

Wolski

Nicholls

Nissen

. Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials. JAMA 2007;298:1180–8.

Solomon

Winkelmayer

. Cardiovascular risk and thiazolinediones. JAMA 2007;298:1216–8.

A Tale of Two Glitazones

Abstract

Get full access to this article

References